<ul class="soc-icons">
  <li><a href="https://vimeo.com/"><i class="vimeo-icon"></i></a></li>
  <li><a href="https://twitter.com/"><i class="twitter-icon"></i></a></li>
  <li><a href="https://www.flickr.com/"><i class="flickr-icon"></i></a></li>
</ul>

<div class="downloads-box">
  <ul class="downloads-list">
    <li class="downloads-list-title">Schema</li>
    <li><a href="#">SARC016-Schema.pdf</a></li>
  </ul>
</div>

<div class="downloads-box">
  <ul class="downloads-list">
    <li class="downloads-list-title">Additional Downloads</li>
    <li><a href="#">File-name.pdf</a></li>
    <li><a href="#">Presentation-name.pptx</a></li>
  </ul>
</div>

<div class="trial-criteria">
  <h2>Eligibility &amp; Exclusion Criteria</h2>
  <h4>Heading I</h4>
  <ul>
    <li>Morbi vulputate, dolor ut rutrum interdum</li>
    <li>Vivamus sed vestibulum nibh</li>
    <li>Pellentesque et leo ut magna dignissim</li>
  </ul>
  <h4>Heading II</h4>
  <ul>
    <li>Morbi vulputate, dolor ut rutrum interdum</li>
    <li>Vivamus sed vestibulum nibh</li>
    <li>Pellentesque et leo ut magna dignissim</li>
  </ul>
</div>

<p><a href="#">View NCT00752206</a> at clinicaltrials.gov</p>
<p class="ital">For more information about this trial and open sites:</p>
<div><a class="btn-reg btn-reg-spot" href="#">Contact SARC</a></div>

<!-- deep link code -->
<a href="submit-a-concept" class="deep-link-float deep-link-right deep-link-a">
<div class="deep-link">
  <h5>Submit a new concept</h5>
  <p>Share your ideas with SARC</p>
</div>
</a>

<!-- homepage feature item -->
<a href="scientific-leadership-committees">
  <span class="homepage-feature-title">Explore SARC Committees</span>
  <p>Meet our experts</p>
</a>

<div class="event-feature">
  <div class="event-center event-center-first">
    <ul class="event-date">
      <li>Friday</li>
      <li class="date">May 30</li>
      <li>2014</li>
    </ul>
  </div>
  <div class="event-center event-center-mid">
    <ul class="event-location">
      <li><h3>SARC Meeting at ASCO</h3></li>
      <li>8:00am - 12:00pm CST</li>
      <li>Hyatt Regency Chicago, IL</li>
    </ul>
  </div>
  <div class="event-center event-center-last">
    <a class="btn-main" href="https://docs.google.com/forms/d/1YgEvvf4BdA7IpQw1WSnOIndO2O5CDEFd6LzmuyUS-7M/viewform" target="_blank" title="RSVP form">RSVP</a>
  </div>
</div>

<ul class="location-info">
  <li>24 Frank Lloyd Wright Drive</li>
  <li>Lobby A, Suite 3100</li>
  <li>Ann Arbor, Michigan 48106</li>
</ul>
<ul class="contact-info">
  <li>Fax: 734.930.7657</li>
  <li class="phone">Phone: 734.930.7600</li>
  <li class="email">Email: <a href="mailto:info@sarctrials.org">info@sarctrials.org</a></li>
</ul>

<div class="participate">
  <h2>Individual Participation</h2>
  <img src="http://placehold.it/460x300">
  <div class="participate-inner">
    <p class="bold">Individuals join SARC for opportunities to:</p>
    <ul>
      <li>Attend SARC meetings and events</li>
      <li>Network and meet potential collaborators</li>
      <li>Participate in discussions and collaborations</li>
      <li>Submit new trial ideas and concepts</li>
      <li>Participate in generating new ideas in research</li>
      <li>Join SARC committees by nomination</li>
      <li>Receive regular updates on events and news via our newsletter</li>
      <li>Apply for funding opportunities, such as an annual Career Development Award or Development Research Program</li>
    </ul>
    <a class="btn-reg btn-lg" href="#">Sign up</a>
  </div>
</div>

<div class="participate">
  <h2>[title]</h2>
  [field_join_image]
  <div class="participate-inner">
    [field_join_content] 
    [field_join_link]
  </div>
</div>


<div class="deep-link">
  <h3><a href="#">Submit a trial concept</a></h3>
  <p>Download application</p>
</div>

<div class="trials">
  <h2>Active SARC Trials</h2>
  <ul class="active-trials">
    <li>
      <h5><a href="#">SARC012</a></h5>
      <p>A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung</p>
      <ul class="details">
        <li><span class="bold">Type of Sarcoma:</span> Osteosarcoma</li>
        <li><span class="bold">Drug:</span> Saracatinib (AZD0530)</li>
        <li><span class="bold">Accrual Status:</span> Open</li>
      </ul>
      <a class="btn-main" href="#">See Details</a>
    </li>
    <li>
      <h5><a href="#">SARC016</a></h5>
      <p>Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors</p>
      <ul class="details">
        <li><span class="bold">Type of Sarcoma:</span> Malignant peripheral nerve sheath tumors</li>
        <li><span class="bold">Drug:</span> Saracatinib (AZD0530)</li>
        <li><span class="bold">Accrual Status:</span> Closed</li>
      </ul>
      <a class="btn-main" href="#">See Details</a>
    </li>
  </ul>
</div>

<div class="trials">
  <h2>Completed SARC Trials</h2>
  <ul class="completed-trials">
    <li>
      <h5><a href="#">SARC012</a></h5>
      <p>A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung</p>
      <ul class="details">
        <li><span class="bold">Type of Sarcoma:</span> Osteosarcoma</li>
        <li><span class="bold">Drug:</span> Saracatinib (AZD0530)</li>
        <li><span class="bold">Accrual Status:</span> Open</li>
      </ul>
      <a class="btn-main" href="#">See Details</a>
    </li>
    <li>
      <h5><a href="#">SARC016</a></h5>
      <p>Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors</p>
      <ul class="details">
        <li><span class="bold">Type of Sarcoma:</span> Malignant peripheral nerve sheath tumors</li>
        <li><span class="bold">Drug:</span> Saracatinib (AZD0530)</li>
        <li><span class="bold">Accrual Status:</span> Closed</li>
      </ul>
      <a class="btn-main" href="#">See Details</a>
    </li>
  </ul>
</div>

<!-- keep for detail page? 
<li><span class="bold">Downloads:</span> 
  <ul>
    <li><a href="#">Publication-Title.pdf</a></li>
    <li><a href="#">Publication-Title.pdf</a></li>
    <li><a href="#">Publication-Title.pdf</a></li>
  </ul>
</li>
-->

<div class="event-item">
  <ul class="event-item-date">
    <li>Thursday</li>
    <li class="event-date">May 05</li>
    <li>2014</li>
  </ul>
  <div class="event-item-info">
    <ul>
      <li>Executive Committee Meeting</li>
      <li>Teleconference</li>
      <li>8PM EST</li>
    </ul>
    <p>Donec gravida malesuada consequat. Morbi pretium justo sed pellentesque aliquet. Ut pellentesque tellus leo, at pellentesque turpis vestibulum ac.</p>
  </div>
</div>

<div class="event-item">
  <ul class="event-item-date">
    <li>Friday</li>
    <li class="event-date">May 30</li>
    <li>2014</li>
  </ul>
  <div class="event-item-info asco">
    <ul>
      <li><a href="#">SARC Meeting at ASCO</a></li>
      <li>Chicago, Illinois</li>
      <li>8AM - 12PM CST</li>
    </ul>
    <p>Mauris tempus vitae risus quis vestibulum. Praesent sapien lacus, posuere dignissim nunc vel, accumsan pharetra arcu. Praesent eu dui ac felis pulvinar venenatis a vitae neque. <a href="#">RSVP now &raquo;</a></p>
  </div>
</div>

<div class="event-item">
  <div class="event-item-date">
    <div class="center">
      <ul>
        <li>Monday</li>
        <li class="event-date">May 05</li>
        <li>2014</li>
      </ul>
    </div>
  </div>
  <div class="event-item-info">
    <div class="center">
      <ul>
        <li>Executive Committee Meeting</li>
        <li>Teleconference</li>
        <li>8PM EST</li>
      </ul>
    </div>
    <p>SARC’s Executive Commitee meets monthly to ed a magna neque. Quisque sollicitudinvenenatis tortor, nec blandit mauris porttitor nec</p>
  </div>
</div>

<h2>Collaborating to cure sarcoma</h2>
<p>The rarity of sarcoma warrants the collaboration of many partners. No other organization offers SARC’s ability to bring together the network of participants and components necessary to bring clinical trials to reality, through an ongoing process of discovery, development and delivery for delivering new and better options.</p>
<div class="value-graph">
  <div class="circle-wrap">
    <div class="circle first-circle">
      <div>Access to sarcoma patients</div>
    </div>
    <div class="icon-plus"></div>
    <div class="circle second-circle">
      <div>Laboratory and clinical experts</div>
    </div>
    <div class="icon-plus"></div>
    <div class="circle third-circle">
      <div>Operational expertise</div>
    </div>
    <ul class="result">
      <li class="icon-equals">=</li>
      <li>FDA Approval</li>
    </ul>
  </div>
</div>

<div class="step">
  <div class="step-number first-number">
    <span>1</span>
  </div>
  <div class="descript">
    <h5>Patients with sarcoma</h5>
    <ul>
      <li class="first-li">Rare disease</li>
      <li>Seek better treatments</li>
      <li class="last-li">Low volume among providers</li>
    </ul>
  </div>
</div>  

<div class="step">
  <div class="step-number middle-number">
    <span>2</span>
  </div>
  <div class="descript">
    <h5>New drugs</h5>
    <ul>
      <li class="first-li">Pharma</li>
      <li>Biotech</li>
      <li class="last-li">Bench Research</li>
    </ul>
  </div>
</div>

<div class="step">
  <div class="step-number middle-number">
    <span>3</span>
  </div>
  <div class="descript">
    <h5>Sarcoma Investigators</h5>
    <ul>
      <li class="first-li">Seek large, statistically significant studies</li>
      <li class="last-li">Need to collaborate</li>
    </ul>
  </div>
</div>

<div class="step">
  <div class="step-number next-last-number">
    <span>4</span>
  </div>
  <div class="descript">
    <h5>Sarcoma Clinical Trials</h5>
    <ul>
      <li class="first-li">Need access to patients</li>
      <li>Requires quality data</li>
      <li class="last-li">Comply with federal regulations</li>
    </ul>
  </div>
</div>

<div class="step">
  <div class="step-number last-number">
    <span>5</span>
  </div>
  <div class="descript">
    <h5>FDA Approval</h5>
    <ul>
      <li class="first-li">New treatment option for patients</li>
      <li class="last-li">New drug approval for company</li>
    </ul>
  </div>
</div>

<!-- value chain from site -->
<h2>Collaborating to cure sarcoma</h2>
<p>The rarity of sarcoma warrants the collaboration of many partners. No other organization offers SARC’s ability to bring together the network of participants and components necessary to bring clinical trials to reality, through an ongoing process of discovery, development and delivery for delivering new and better options.</p>
<div class="value-graph">
  <div class="circle-wrap">
    <div class="circle first-circle">
      <div>Sarcoma Patients</div>
    </div>
    <div class="icon-plus"></div>
    <div class="circle second-circle">
      <div>Laboratory and Clinical Experts</div>
    </div>
    <div class="icon-plus"></div>
    <div class="circle third-circle">
      <div>Research Infrastructure</div>
    </div>
    <ul class="result">
      <li class="icon-equals">=</li>
      <li>ADVANCING TREATMENTS FOR SARCOMA</li>
    </ul>
  </div>
</div>

<div class="step first-step">
  <div class="step-number first-number">1</div>
  <div class="descript">
    <h5>Patients with sarcoma</h5>
    <ul>
      <li class="first-li">Need better treatments</li>
      <li class="last-li">Seek sarcoma clinical experts</li>
    </ul>
  </div>
</div>
<div class="step">
  <div class="step-number middle-number">2</div>
  <div class="descript">
    <h5>Experts in Sarcoma</h5>
    <ul>
      <li class="first-li">Recognize the value of collaboration</li>
      <li class="last-li">Seek better options for their patients</li>
    </ul>
  </div>
</div>
<div class="step">
  <div class="step-number middle-number">3</div>
  <div class="descript">
    <h5>Pharmaceutical &amp; Biotech Companies</h5>
    <ul>
      <li class="first-li">Pharmaceutical and Biotech</li>
      <li class="last-li">Interest in developing new compounds and drugs</li>
    </ul>
  </div>
</div>
<div class="step">
  <div class="step-number next-last-number">4</div>
  <div class="descript">
    <h5>Research Infrastructure</h5>
    <ul>
      <li class="first-li">Laboratory expertise with assays, cell lines and mouse models</li>
      <li>Expertise in key components required for quality clinical and laboratory conduct</li>
      <li class="last-li">Data repository of clinical research</li>
    </ul>
  </div>
</div>
<div class="step">
  <div class="step-number last-number">5</div>
  <div class="descript">
    <h5>Delivery of New and Better Treatments</h5>
    <ul>
      <li class="first-li">Moving forth scientific understanding of sarcoma</li>
      <li class="last-li">Supporting the application for approval of new drugs</li>
    </ul>
  </div>
</div>


<ul class="anchor-nav">
  <li><a href="#">A - F</a></li>
  <li><a href="#">G - L</a></li>
  <li><a href="#">M - R</a></li>
  <li><a href="#">S - Z</a></li>
</ul>

<ul class="subtypes-list">
  <li>
    <h3>Alveolar Soft Part Sarcoma</h3>
    <p>Alveolar Soft Part Sarcoma is an extremely rare sarcoma that typically arises in the thigh or buttock of someone in their 20’s. Men are much more commonly affected than women. While it does not appear particularly aggressive under the microscope, it travels very early to other sites of the body, including lung, chest cavity, liver, and bone, and occasionally to brain. This form of sarcoma is relatively resistant to standard chemotherapy. Despite the early spread of tumor, people with this diagnosis can live for 10-20 years or more after diagnosis, in some cases.</p>
  </li>
  <li>
    <h3>Atypical fibroxanthoma</h3>
    <p>Atypical Fibroxanthoma is an unusual and relatively less aggressive form of sarcoma that shows features of both fibroblasts and cells that retain fat (xanthomas). The primary treatment is surgical. Radiation is occasionally used to try and prevent tumor recurrence, and chemotherapy is felt largely ineffective for this diagnosis. These tumors only very, very rarely metastasize.</p>
  </li>
  <li>
    <h3>Bone and cartilage sarcomas of soft tissue</h3>
    <p>Bone and Cartilage Sarcomas of Soft Tissue: Some sarcomas that arise in soft tissue mimic those that typically arise in cartilage or bone. Many of these sarcomas have some (but not all) features in common with their bone tumor equivalents, and each has unique characteristics that must be considered in their treatment.</p>
  </li>
  <li>
    <h3>Clear cell sarcoma</h3>
    <p>Clear Cell Sarcoma (melanoma of soft parts) is an unusual hybrid tumor that appears to be biologically related to alveolar soft part sarcoma. It is one of the rare tumors with features of both sarcoma and melanoma, including the ability to travel to lymph nodes (typical of melanoma) and to lung (more common for sarcomas). Surgery and radiation of the primary tumor site provide the best chance for cure.</p>
  </li>
  <li>
    <h3>Dermatofibrosarcoma Protuberans</h3>
    <p>Clear Cell Sarcoma (melanoma of soft parts) is an unusual hybrid tumor that appears to be biologically related to alveolar soft part sarcoma. It is one of the rare tumors with features of both sarcoma and melanoma, including the ability to travel to lymph nodes (typical of melanoma) and to lung (more common for sarcomas). Surgery and radiation of the primary tumor site provide the best chance for cure.</p>
  </li>
  <li>
    <h3>Desmoplastic small round cell tumor</h3>
    <p>Clear Cell Sarcoma (melanoma of soft parts) is an unusual hybrid tumor that appears to be biologically related to alveolar soft part sarcoma. It is one of the rare tumors with features of both sarcoma and melanoma, including the ability to travel to lymph nodes (typical of melanoma) and to lung (more common for sarcomas). Surgery and radiation of the primary tumor site provide the best chance for cure.</p>
  </li>
  <li>
    <h3>Epithelioid Sarcoma</h3>
    <p>Epithelioid Sarcoma is another form of sarcoma that typically affects tumor of the extremities (arms and legs) and tends to travel early to other sites of the body. Similar to people with alveolar soft part sarcoma, people can live for a long time with despite metastatic disease. Unlike other sarcomas, epithelioid sarcoma can travel to lymph nodes and cause side effects from involving multiple lymph nodes is a given area of the body.</p>
  </li>
  <li>
    <h3>Ewing’s sarcoma / primitive neutroectodermal tumor</h3>
    <p>Ewing's Sarcoma / Primitive NeuroEctodermal Tumor (PNET) is another family of sarcomas. This group of sarcomas typically occurs in children or young adults, although cases in people up to age 80 or more are occasionally seen. We estimate there are fewer than 500 cases a year in the United States. Without chemotherapy the cure rate is at best 10%, but with chemotherapy a cure rate of up to 75% in children and 50-60% in adults is seen. Surgery and radiation are also commonly used as treatment for the primary tumor in order to try to achieve the highest cure rate possible. Ewing sarcomas appear to affect bone in children and soft tissue in adults, and can be seen in any site of the body. They commonly recur in the lungs and bones.</p>
  </li>
</ul>

<div class="event-item">
  <div class="event-item-date">
    <span>Friday</span>
    <span class="event-date">May 30</span>
    <span>2014</span>
  </div>
  <div class="event-item-info asco">
    <h3><a href="#">SARC Meeting at ASCO</a></h3> 
    <ul>
      <li>Teleconference</li>
      <li>7PM EST</li>
    </ul>
    <p>Donec gravida malesuada consequat. Morbi pretium justo sed pellentesque aliquet. Ut pellentesque tellus leo, at pellentesque turpis vestibulum ac.</p>
  </div>
</div>

<div class="event-item">
  <div class="event-item-date">
    <span>Thursday</span>
    <span class="event-date">May 05</span>
    <span>2014</span>
  </div>
  <div class="event-item-info">
    <h3>Executive Committee Meeting</h3> 
    <ul>
      <li>Teleconference</li>
      <li>8PM EST</li>
    </ul>
    <p>SARC’s Executive Commitee meets monthly to ed a magna neque. Quisque sollicitudinvenenatis tortor, nec blandit mauris porttitor nec. <a href="#">Learn more about SARC&rasquo;s organization structure</a></p>
  </div>
</div>

<div class="org">
  <h2>Board of Directors</h2>
  <p>Pellentesque sed arcu et arcu sagittis ultrices. Integer ante nulla, aliquam a augue quis, fermentum pellentesque arcu. Sed hendrerit metus in velit euismod facilisis. Curabitur venenatis massa sit amet consectetur volutpat.</p>
  <ul class="member">
    <li><h3>McHenry Tichenor</h3></li>
    <li>Board Chair</li>
    <li><a href="#">View bio</a></li>
  </ul>
  <ul class="member">
    <li><h3>Kapil Dhingra, MD</h3></li>
    <li>Title</li>
    <li><a href="#">View bio</a></li>
  </ul>
  <ul class="member">
    <li><h3>Mark Thornton, MD, PhD</h3></li>
    <li>Title</li>
    <li><a href="#">View bio</a></li>
  </ul>
  <ul class="member">
    <li><h3>Gene Rosenfeld, CPA</h3></li>
    <li>Title</li>
    <li><a href="#">View bio</a></li>
  </ul>
  <ul class="member">
    <li><h3>Lee Helman, MD</h3></li>
    <li>National Cancer Institute liaison to SARC Board</li>
    <li><a href="#">View bio</a></li>
  </ul>
</div>

<div class="centers-intro">
  <h1>[title]</h1>
  <p>[field_intro]</p>
  <div class="intro-btns">
    <a href="#">List View</a>
    <a href="#">Map View</a>
  </div>
</div>

<!-- o   University of Michigan, Ann Arbor

o   MD Anderson Cancer Center, Houston

o   University of Iowa, Iowa City

o   Children’s Hospital of Pittsburgh

o   Sarcoma Oncology Center, Santa Monica CA-->

<ul class="centers-list">
  <li class="centers-item">
    <h3>California</h3>
    <ul>
      <li><a href="#">Sarcoma Oncology Center</a></li>
      <li>2811 Wilshire Blvd #414</li>
      <li>Santa Monica, California 90403</li>
      <li>310.552.9999</li>
    </ul>
    <a href="#">View on Google Maps</a>
  </li>
  <li class="centers-item">
    <h3>Iowa</h3>
    <ul>
      <li><a href="#">University of Iowa</a></li>
      <li>2811 Wilshire Blvd #414</li>
      <li>Iowa City, Iowa 52242</li>
      <li>319.335.3500</li>
    </ul>
    <a href="#">View on Google Maps</a>
  </li>
  <li class="centers-item">
    <h3>Michigan</h3>
    <ul>
      <li><a href="#">University of Michigan</a></li>
      <li>500 S State Street</li>
      <li>Ann Arbor, Michigan 48109</li>
      <li>734.764.1817</li>
    </ul>
    <a href="#">View on Google Maps</a>
  </li>
</ul>

<h1>SARC Meeting at ASCO</h1>
<img src="http://placehold.it/585x310" alt="placeholder">
<div class="event-details">
  <ul>
    <li class="bold">May 30, 2014</li>
    <li>8am - 12pm CST</li>
    <li>Hyatt Regency Chicago | Chicago, IL</li>
  </ul>
  <a class="btn-main" href="#">RSVP</a>

  <h3>Downloads</h3>
  <ul>
    <li><a href="#">2014-Meeting-Agenda.pdf</a></li>
    <li><a href="#">2014-ASCO-Schedule.pdf</a></li>
  </ul>
</div>

<ul class="funding-list">
  <li><a class="btn-main" href="#">Apply for Career Development Award</a></li>
  <li><a class="btn-main" href="#">Apply for Development Research Program</a></li>
</ul>

<ul class="homepage-feature">
  <li>
    <a href="#"><img src="http://placehold.it/465x300" alt="placeholder image"></a>
    <div class="homepage-feature-content">
      <a class="homepage-feature-a" href="#">Participate in a study</a>
      <p class="support-text">View open trials</p>
    </div>
  </li>
  <li>
    <a href="#"><img src="http://placehold.it/465x300" alt="placeholder image"></a>
    <div class="homepage-feature-content">
      <a href="#">Bring your drug to market</a>
      <p class="support-text">Learn about drug development</p>
    </div>
  </li>
  <li> 
    <a href="#"><img src="http://placehold.it/465x300" alt="placeholder image"></a>
    <div class="homepage-feature-content">
      <a class="homepage-feature-a" href="#">Join a committee</a>
      <p class="support-text">Submit for consideration</p>
    </div>
  </li>
  <li>  
    <a href="#"><img src="http://placehold.it/465x300" alt="placeholder image"></a>
    <div class="homepage-feature-content">
      <a class="homepage-feature-a" href="#">Submit a trial concept</a>
      <p class="support-text">Download application</p>
    </div>
  </li>
</ul>

<div class="homepage-feat-item">
  [field_image_feature]
  <div class="homepage-feature-content">
    [field_feature_link]
    <p class="support-text">[field_tagline]</p>
  </div>
</div>


<h1 class="main-h1">SARC012 <span>| Active</span></h1>
<p>A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung</p>
<ul class="details">
  <li><span class="bold">Type of Sarcoma:</span> Osteosarcoma</li>
  <li><span class="bold">Excluded:</span> Odio et vehicula, Tempor scelerisque</li>
  <li><span class="bold">Drug:</span> Saracatinib (AZD0530)</li>
  <li><span class="bold">Accrual Status:</span> Open</li>
  <li> 
    <ul class="downloads">
      <li><span class="bold">Downloads:</span></li>
      <li><a href="#">Publication-Title.pdf</a></li>
      <li><a href="#">Publication-Title.pdf</a></li>
      <li><a href="#">Publication-Title.pdf</a></li>
    </ul>
  </li>
  <li class="last-detail"><span class="bold">Principal Investigator:</span> First and Last Name | Title</li>
</ul>
<p><span class="bold">Summary:</span> After complete surgical removal of their cancer, patients will be randomly assigned to receive either Saracatinib or placebo (a sugar pill) throughout the study. Patients will take Saracatinib (or placebo) once daily by mouth for a total of 364 days. The duration of treatment is divided into 13 cycles, 28 days each cycle with no breaks in between.</p>
<div class="global-container">
  <h2 class="global-subhead">Schema</h2>
  <a class="download-file" href="#">Download PDF</a>
  <h3>Outline Heading 1</h3>
  <ul class="main-list">
    <li>Etiam auctor ultricies odio et vehicula.</li>
    <li>In eget dolor quis nulla tempor scelerisque.</li>
    <li>Duis auctor felis ut eros mattis, eget vulputate mi vehicula.</li>
    <li>Pellentesque euismod convallis adipiscing.</li>
    <li>Mauris vitae metus neque.</li>
  </ul>
  <h3>Outline Heading 2</h3>
  <ul class="main-list">
    <li>Etiam auctor ultricies odio et vehicula.</li>
    <li>In eget dolor quis nulla tempor scelerisque.</li>
    <li>Duis auctor felis ut eros mattis, eget vulputate mi vehicula.</li>
    <li>Pellentesque euismod convallis adipiscing.</li>
    <li>Mauris vitae metus neque.</li>
  </ul>
  <h3>Outline Heading 3</h3>
  <ul class="main-list">
    <li>Etiam auctor ultricies odio et vehicula.</li>
    <li>In eget dolor quis nulla tempor scelerisque.</li>
    <li>Duis auctor felis ut eros mattis, eget vulputate mi vehicula.</li>
    <li>Pellentesque euismod convallis adipiscing.</li>
    <li>Mauris vitae metus neque.</li>
  </ul>
</div>
<p>For more information about this trial:</p>
<a class="btn-main" href="#">Contact SARC</a>

<ul class="anchor-nav">
  <li><a href="#">A - F</a></li>
  <li><a href="#">G - L</a></li>
  <li><a href="#">M - R</a></li>
  <li><a href="#">S - Z</a></li>
</ul>

<ul class="centers-list">
  <li class="centers-item">
    <h3>California</h3>
    <ul>
      <li><a href="#">Sarcoma Oncology Center</a></li>
      <li>2811 Wilshire Blvd #414</li>
      <li>Santa Monica, California 90403</li>
      <li>310.552.9999</li>
    </ul>
    <a href="#">View on Google Maps</a>
  </li>
  <li class="centers-item">
    <h3>Iowa</h3>
    <ul>
      <li><a href="#">University of Iowa Hospitals & Clinics</a></li>
      <li>200 Hawkins Drive, C32-J-GH</li>
      <li>Iowa City, Iowa 52242</li>
      <li>800.777.8442</li>
    </ul>
    <a href="#">View on Google Maps</a>
  </li>
  <li class="centers-item">
    <h3>Michigan</h3>
    <ul>
      <li><a href="#">University of Michigan Comprehensive Cancer Center</a></li>
      <li>1500 East Medical Center Drive, CCGC 6-303</li>
      <li>Ann Arbor, Michigan 48109</li>
      <li>800.865.1125</li>
    </ul>
    <a href="#">View on Google Maps</a>
  </li>
</ul>

<div class="event-item">
  <div class="event-item-date">
    <span>Thursday</span>
    <span class="event-date">May 05</span>
    <span>2014</span>
  </div>
  <div class="event-item-info">
    <h3>Executive Committee Meeting</h3> 
    <ul>
      <li>Teleconference</li>
      <li>8PM EST</li>
    </ul>
    <p>SARC’s Executive Commitee meets monthly to ed a magna neque. Quisque sollicitudinvenenatis tortor, nec blandit mauris porttitor nec. <a href="#">Learn more about SARC's organization structure</a>.</p>
  </div>
</div>

<div class="event-item">
  <div class="event-item-date">
    <span>Wednesday</span>
    <span class="event-date">May 15</span>
    <span>2014</span>
  </div>
  <div class="event-item-info">
    <h3>Clinical Trials Review Call</h3> 
    <ul>
      <li>Teleconference</li>
      <li>8PM EST</li>
    </ul>
    <p>Donec gravida malesuada consequat. Morbi pretium justo sed pellentesque aliquet. Ut pellentesque tellus leo, at pellentesque turpis vestibulum ac.</p>
  </div>
</div>

<div class="event-item">
  <div class="event-item-date">
    <span>[field_day]</span>
    <span class="event-date">[field_date]</span>
    <span>[field_year]</span>
  </div>
  <div class="event-item-info asco">
    <h3 class="title">[title]</h3> 
    <ul>
      <li>[field_location]</li>
      <li>[field_time]</li>
    </ul>
    <p>[field_event_description]</p>
  </div>
</div>

<div class="event-feature">
  <div class="event-center event-center-first">
    <ul class="event-date">
      <li>[field_day]</li>
      <li class="date">[field_date]</li>
      <li>[field_year]</li>
    </ul>
  </div>
  <div class="event-center event-center-mid">
    <ul class="event-location">
      <li><h3><a href="#">[title]</a></h3></li>
      <li>[field_time]</li>
      <li>[field_location]</li>
    </ul>
  </div>
  <div class="event-center">
    <a class="btn-reg btn-lg" href="https://docs.google.com/forms/d/1YgEvvf4BdA7IpQw1WSnOIndO2O5CDEFd6LzmuyUS-7M/viewform" target="_blank" title="RSVP form">RSVP</a>
  </div>
</div>

<div class="org">
  <h2>Board of Directors</h2>
  <p>Pellentesque sed arcu et arcu sagittis ultrices. Integer ante nulla, aliquam a augue quis, fermentum pellentesque arcu. Sed hendrerit metus in velit euismod facilisis. Curabitur venenatis massa sit amet consectetur volutpat.</p>
  <ul class="member">
    <li><h3>McHenry Tichenor</h3></li>
    <li>Board Chair</li>
    <li><a href="#">View bio</a></li>
  </ul>
  <ul class="member">
    <li><h3>Kapil Dhingra, MD</h3></li>
    <li>Title</li>
    <li><a href="#">View bio</a></li>
  </ul>
  <ul class="member">
    <li><h3>Mark Thornton, MD, PhD</h3></li>
    <li>Title</li>
    <li><a href="#">View bio</a></li>
  </ul>
  <ul class="member">
    <li><h3>Gene Rosenfeld, CPA</h3></li>
    <li>Title</li>
    <li><a href="#">View bio</a></li>
  </ul>
  <ul class="member">
    <li><h3>Lee Helman, MD</h3></li>
    <li>National Cancer Institute liaison to SARC Board</li>
    <li><a href="#">View bio</a></li>
  </ul>
</div>


<p class="intro-text">[field_intro]</p>
<div class="intro-btns">
  <a class="btn-reg btn-lg" href="bone-sarcoma">Bone Sarcoma</a>
  <a class="btn-reg btn-lg btn-right" href="soft-tissue-sarcoma">Soft Tissue Sarcoma</a>
</div>

<div class="meeting-info">
  [field_meeting_info] 
</div>
[field_rsvp_btn]


<p class="intro-text">[field_intro]</p>
<a class="btn-reg btn-lg" href="https://www.paypal.com/en_US/i/btn/btn_donateCC_LG.gif">Donate</a>

<div class="sarc-centers-inner">
<p>Our member institutions, centers, and practices participating in sarcoma research trials are located across the United States, and around the world. This map will help you quickly identify the SARC constituents that offer the commitment and infrastructure to be involved in sarcoma research at the laboratory or clinical level.</p>
<p>Please note that the SARC centers identified here may not have active clinical trials at this time. Visit SARC Clinical Trials to learn which trials are open, closed, or accepting new patients.</p>
<p>If your institution, center, or practice is interested in becoming a SARC Center and being represented on the SARC map, we invite you to join us in our work.</p>
<p>Updates to our SARC map? Please let us know at sarc@sarctrials.org</p>

<p>Choosing a treatment path and whether or not to participate in a clinical trial can be a very difficult decision. This is a question only you, those close to you, and health professionals familiar with your situation can consider and answer together.</p>
 
<h2>What Are Clinical Trials?</h2>
<p>Clinical trials are research studies conducted with human patients. The trials are designed to discover improvements in prevention, diagnosis, or treatment options for a disease, such as sarcoma. They are part of a meticulous research process in which patients receive a new treatment (a new drug, new approach to surgery or radiation therapy, or new combination of treatments) that already has been researched in successful laboratory and or animal studies. Some clinical trials may even study drugs or procedures that have already been approved by the US Food & Drug Administration (FDA)  for a different purpose. Most of the widely accepted medicines and treatments used by today’s medical experts are based on the results of previous clinical trials.</p>
 
<h2>Why Participate?</h2>
<p>It is often thought that clinical trials are a last resort, but they may in fact be a good way to begin your treatment and receive excellent care from the very start. Of course, certain trials may not be right for all patients, based on eligibility criteria (requirements that patients must meet before they can participate - such as age, gender, subtype and stage of cancer, previous treatments, and other medical conditions) or availability. But if you find a trial that is right for you, you will have access to cutting-edge medicine and health experts, and constant monitoring of your progress.</p>
 
 
<p>Additionally, your participation in clinical trials may contribute to the search for ways to prevent, detect, or treat the disease. As a direct result of patients' participation in past clinical trials, people with cancer are today living longer. All patients in clinical trials are volunteers, so they can stop their participation at any time.</p>
 
<p>However, there is no guarantee that a new treatment being tested will yield good results. New treatments may also have unknown risks, so before you make this decision, you should think about it carefully, considering all other possible treatment choices, and communicate with your doctor to help decide if this is truly the best option.</p>
 
<h2>Informed Consent Process</h2>
<p>If your doctor offers you the option to participate in a clinical trial, you will first take part in a process called informed consent. In this process you will learn about a specific clinical trial so that you may decide whether you want to participate.</p>
 
<p>The researcher or nurse from the clinical trial team will review the informed-consent form in detail with you. This form explains the purpose of a specific clinical trial and its procedures, risks, and potential benefits.</p>
 
<p>An informed-consent form should include: the reason for the trial, what researchers wish to learn from the results of this trial, who is eligible to take part in the trial, what is known about the type of treatment being studied, the possible risks and benefits, other treatments that may be options, the trial's design (randomized, single blind, or double blind), types of tests, the number of doctors visits required, who is responsible for the costs, a statement about conflicts of interest, patient privacy, and patient rights. Should you decide to participate, you, the trial’s primary investigator, and a witness must sign and date the informed-consent form.</p>
 
<p>You will be encouraged to ask questions about terms or ideas that are confusing. A family member or friend may help by attending your appointments with you to listen to the doctor's explanations, ask additional questions, and record the answers. You can also record the conversation and review the information afterward.</p>
 
<p>The informed-consent process also continues throughout the study. Patients will be told of any new discoveries regarding the progress of the trial, such as new risks. At that time, you may be asked to sign a new consent form to stay in the study.</p>
 
<p>Even after signing the informed-consent form, a patient can choose to withdraw from a trial at anytime, for any reason.</p>
 
<p>Learn more about active SARC Clinical Trials here.</p>

<div class="latest-item">
  <h2>[title]</h2>
  <div class="item-sub-title">[field_current_affiliation]</div>
  [field_bio_image]
  <div class="item-copy">[field_bio_copy]</div>
</div>

<div class="latest-item">
  <h2>[title]</h2>
  <div class="item-sub-title">[field_sub_title]</div>
  <div class="item-copy">[field_news_copy]</div>
</div>

<div class="disclaimer">
  <p>SARC facilitates the conduct of research and therefore engages partners to do this important work. SARC’s Board of Directors limits the amount our partners can spend on overhead costs. A maximum of 25 cents per dollar (or 25%) can be used for infrastructure or indirect cost. <span class="bold">Therefore 75% of funds are retained to directly support research activities</span>.</p>
</div>

<div class="donate-in-honor">
  <p>You can help our research either by donating online, via PayPal, or by check.</p>
  <a class="btn-reg btn-lg" href="#">Donate</a>
  <p>Checks should be made payable to SARC and mailed to:</p>
  <ul class="address">
    <li>24 Frank Lloyd Wright Drive</li>
    <li>Lobby A, Suite 3100</li>
    <li>Ann Arbor, Michigan 48105</li>
  </ul>
  <p>If you have any questions about your contribution please call us at 734-930-7657.</p>
  <h3>To make a contribution in honor of a loved one</h3>
  <p>This is a placeholder text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla tempus risus ipsum, non egestas arcu accumsan eget. Maecenas in elit auctor, molestie tortor sit amet, accumsan sem. This is a placeholder text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla tempus risus ipsum, non egestas arcu accumsan eget. Maecenas in elit auctor, molestie tortor sit amet, accumsan sem.</p>
  <ul>
    <li>If you choose to make a contribution in honor or in memory of someone, please include a note    with your donation.</li>
    <li>Your donation may be tax deductible.</li>
    <li>We will send you a letter acknowledging receipt of your donation.</li>
  </ul>
  <p><a href="#">Read the stories</a> of the loved ones we honor.</p>
</div>

<ul>
  <li>Have sarcoma expertise at a multidisciplinary level (i.e. surgical oncology, medical oncology, pediatric oncology, orthopaedic oncology, radiation therapy, pathology and radiology)</li>
  <li>Have a significant sarcoma program that sees at least 70 new cases of sarcoma annually</li>
  <li>Demonstrate experience in conducting sarcoma clinical research (for the Clinical Research Committee) and/or laboratory translational research (for the Developmental Therapeutics Committee)</li>
</ul>

<div class="sarc-committee">
  <h2 class="committee-name">Clinical Research Committee</h2>
  <ul>
     <li>Shreyaskumar Patel, MD <div class="committee-role">Chair</div></li>
     <li>Kristen Ganjoo, MD</li>
     <li>Richard Gorlick, MD</li>
     <li>Scott Schuetze, MD, PhD</li>
     <li>William Tap, MD</li>
     <li>Andrew Wagner, MD, PhD</li>
     <li>Scott Okuno, MD</li>
     <li>Robert Maki, MD, PhD</li>
  </ul>
  <h3>Ad Hoc Members</h3>
  <ul>
    <li>John Crowley, PhD</li>
    <li>Chand Khanna, DVM, PhD</li>
    <li>Scott Okuno, MD</li>
    <li>Denise Reinke, MS, NP, MBA</li>
  </ul>
</div>

<div class="sarc-committee">
  <h2 class="committee-name">Developmental Therapeutics Committee</h2>
  <ul>
     <li>Chand Khanna, DVM, PhD <div class="committee-role">Chair</div></li>
     <li>Peter Houghton, PhD</li>
     <li>David Kirsch, PhD</li>
     <li>Raphael Pollock, MD, PhD</li>
     <li>Poul Sorensen, MD</li>
     <li>Jeffrey Trent, PhD</li>
  </ul>
  <h3>Ad Hoc Members</h3>
  <ul>
    <li>Shreyaskumar Patel, MD</li>
    <li>Denise Reinke, MS, NP, MBA</li>
  </ul>
</div>

<div class="sarc-committee">
  <h2 class="committee-name">Concept Review Committee</h2>
  <ul>
     <li>Rashmi Chugh, MD <div class="committee-role">Chair</div></li>
     <li>John Crowley, PhD</li>
     <li>Robin Jones, MD, MRCP</li>
     <li>Anders Kolb, MD</li>
     <li>Scott Okuno, MD</li>
     <li>Hussein Tawbi, MD, PhD</li>
     <li>Denise Reinke, MS, NP, MBA</li>
  </ul>
</div>

<div class="sarc-committee">
  <h2 class="committee-name">Clinical Trials Review Committee</h2>
  <ul>
     <li>Scott Okuno, MD <div class="committee-role">Chair</div></li>
     <li>Scott Schuetze, MD, PhD <div class="committee-role">Principal Investigator SARC009</div></li>
     <li>Melinda Merchant, MD <div class="committee-role">Principal Investigator SARC012</div></li>
     <li>Brigitte Widemann, MD <div class="committee-role">Principal Investigator SARC016</div></li>
     <li>James Butrynski, MD <div class="committee-role">Principal Investigator SARC020</div></li>
     <li>William Tap, MD <div class="committee-role">Principal Investigator SARC021</div></li>
     <li>Margaret Von Mehren, MD <div class="committee-role">Principal Investigator SARC022</div></li>
     <li>AeRang Kim, MD, PhD <div class="committee-role">Principal Investigator SARC023</div></li>
     <li>Robert Maki, MD, PhD <div class="committee-role">Principal Investigator SARC024</div></li>
     <li class="left-indent">Christopher Ryan, MD <div class="committee-role">Co-Principal Investigator SARC024</div></li>
     <li class="left-indent">Steven Attia, DO <div class="committee-role">Co-Principal Investigator SARC024</div></li>
     <li class="left-indent">Richard Riedel, MD <div class="committee-role">Co-Principal Investigator SARC024</div></li>
     <li>Rashmi Chugh, MD <div class="committee-role">Co-Principal Investigator, ESP1/SARC025</div></li>
     <li>Sandra Strauss, MD, PhD <div class="committee-role">Co-Principal Investigator, ESP1/SARC025</div></li>
     <li>John Crowley, PhD</li>
  </ul>
</div>

<!-- value graph archive -->
<div class="step first-step">
  <div class="step-number first-number">1</div>
  <div class="descript">
    <h5>Patients with sarcoma</h5>
    <ul>
      <li class="first-li">Need better treatments</li>
      <li class="last-li">Seek sarcoma clinical experts</li>
    </ul>
  </div>
</div>
<div class="step">
  <div class="step-number middle-number">2</div>
  <div class="descript">
    <h5>Experts in Sarcoma</h5>
    <ul>
      <li class="first-li">Recognize the value of collaboration</li>
      <li class="last-li">Seek better options for their patients</li>
    </ul>
  </div>
</div>
<div class="step">
  <div class="step-number middle-number">3</div>
  <div class="descript">
    <h5>Pharmaceutical &amp; Biotech Companies</h5>
    <ul>
      <li class="first-li">Pharmaceutical and Biotech</li>
      <li class="last-li">Interest in developing new compounds and drugs</li>
    </ul>
  </div>
</div>
<div class="step">
  <div class="step-number next-last-number">4</div>
  <div class="descript">
    <h5>Research Infrastructure</h5>
    <ul>
      <li class="first-li">Laboratory expertise with assays, cell lines and mouse models</li>
      <li>Expertise in key components required for quality clinical and laboratory conduct</li>
      <li class="last-li">Data repository of clinical research</li>
    </ul>
  </div>
</div>
<div class="step">
  <div class="step-number last-number">5</div>
  <div class="descript">
    <h5>Delivery of New and Better Treatments</h5>
    <ul>
      <li class="first-li">Moving forth scientific understanding of sarcoma</li>
      <li class="last-li">Supporting the application for approval of new drugs</li>
    </ul>
  </div>
</div>

